Key statistics
On Friday, Simcere Pharmaceutical Group Ltd (2096:HKG) closed at 6.61, -13.71% below its 52-week high of 7.66, set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.78 |
---|---|
High | 6.86 |
Low | 6.59 |
Bid | 6.61 |
Offer | 6.62 |
Previous close | 6.78 |
Average volume | 11.31m |
---|---|
Shares outstanding | 2.53bn |
Free float | 736.05m |
P/E (TTM) | -- |
Market cap | 17.13bn HKD |
EPS (TTM) | -0.4528 HKD |
Annual div (ADY) | 0.1757 HKD |
---|---|
Annual div yield (ADY) | 2.56% |
Div ex-date | Jun 18 2024 |
Div pay-date | Jul 15 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Press releases
- World Stroke Congress | TASTE-2 significantly reduces stroke disability
- TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability
- Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
- Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor